跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AN-019
首页
药物
AN-019
AN-019
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pharmaceutical compositions comprising phenylaminopyrimidine derivative
US 10383872 B2
申请人: NATCO PHARMA LTD
优先权: 2015
CN
US
2 件公开
Crystal form of phenylamino pyrimidine derivatives
US 8067422 B2
申请人: KOMPELLA AMALA KISHAN
优先权: 2008
US
2 件公开
Formulation comprising phenylaminopyrimidine derivative as active agent
US 9895367 B2
申请人: PARVATANENI DURGA MAHESWARI
优先权: 2011
US
2 件公开
Napyradiomycins compound and application thereof in preparation of anti-inflammatory drugs
CN 119798273 A
申请人: BINZHOU MEDICAL COLLEGE
优先权: 2025
CN
2 件公开
PHENYLAMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF BCR-ABL KINASE
US 2008306100 A1
申请人: NATCO PHARMA LTD
优先权: 2008
US
Application of tRF-Ile-AAT-019 agonist in preparation of medicine for treating psoriasis
CN 114159565 A
申请人: HUNAN AND YA THREE HOSPITAL OF CHINESE AND SOUTH UNIV
优先权: 2021
CN
杀虫蛋白的用途
CN 119823240 B
申请人: 北京大北农生物技术有限公司
优先权: 2024
CN
SMIC capture antibody, kit and application of sMIC capture antibody
CN 118294656 A
申请人: GUANGZHOU KONCEN BIOTECHNOLOGY CO LTD
优先权: 2024
CN
药物
反馈